Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 25
Federal Government Announces Plan to Ban Ephedra
Journal Top Ten -- COLUMNS-Drugs & Supplements -- January 2004
The Impact of HIPAA on Ex Parte Interviews with Plaintiffs' Treating Physicians: Preemption or Red Herring?, Part One
The Impact of HIPAA on Ex Parte Interviews with Plaintiffs' Treating Physicians: Preemption or Red Herring?, Part Two
Warnings -- COLUMNS-Drugs & Supplements -- January 2004
Defendants' Motion to Stay Proceedings Pending Transfer to PPA MDL Granted
Oregon Couple Sues Metabolife Claiming Supplement Caused Stoke
Plaintiffs File Opposition to Lilly's Petition for Zyprexa MDL
